Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Even when we're resting, our brains are preparing us to be social

  • As people non-consciously categorize others by political affiliation, they ignore race, but not age or gender

  • News may influence racial bias

  • Researchers unravel a link between a genetic mutation and autistic behaviors, then find a way to undo it

  • How sleep helps us learn and memorize

  • Scientists retrieve lost memories using optogenetics

  • Implicit social biases made to drop away during sleep

  • Impulsivity linked to binge eating

  • Sleep quality influences cognitive performance of autistic, neurotypical children

  • Brain circuit that controls decisions that induce high anxiety identified

  •